← back to search

Diwei Huo

Harbin Medical University · CN
Area of research
Pulmonary and Respiratory Medicine · Computational Theory and Mathematics
Research interest
Research focused on Gene and Tumor microenvironment, with related work in Drug, Glioma, Interpretability. Notable publications include 'CHG: A Systematically Integrated Database of Cancer Hallmark Genes', 'Impact of Hashimoto’s thyroiditis on the tumor microenvironment in papillary thyroid cancer: insights from single-cell analysis', and 'Crosstalk of different cell-death patterns predicts prognosis and drug sensitivity in glioma'.
h-index
citations
89
works
9
NIH funding
primary concept
email

Recent publications

Increased antiandrogen enzalutamide sensitivity via altering prostate cancer stem cell traits through modulating the androgen receptor-mediated CDR1/circCDR1-AS/miR-1290/BMP4 signaling
Oncogene 2025cited by 1position: firstdoi
Impact of Hashimoto’s thyroiditis on the tumor microenvironment in papillary thyroid cancer: insights from single-cell analysis
Frontiers in Endocrinology 2024cited by 8position: middledoi
Crosstalk of different cell-death patterns predicts prognosis and drug sensitivity in glioma
Computers in Biology and Medicine 2024cited by 6position: middledoi
Predicting drug synergy using a network propagation inspired machine learning framework
Briefings in Functional Genomics 2024cited by 6position: middledoi
A deep learning drug screening framework for integrating local-global characteristics: A novel attempt for limited data
Heliyon 2024cited by 1position: middledoi
Integrating multiple machine learning algorithms for prognostic prediction of gastric cancer based on immune-related lncRNAs
Frontiers in Genetics 2023cited by 4position: middledoi
CHG: A Systematically Integrated Database of Cancer Hallmark Genes
Frontiers in Genetics 2020cited by 57position: middledoi
Predicting hepatocellular carcinoma through cross-talk genes identified by risk pathways
Oncotarget 2018cited by 2position: middledoi
Prediction on the risk population of idiosyncratic adverse reactions based on molecular docking with mutant proteins
Oncotarget 2017cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiujie Chen · Sun Yat-sen University Cancer Center9 papers (2017–2025)Denan Zhang · Ningbo University7 papers (2017–2024)Hongbo Xie · Nanchang University5 papers (2017–2024)Qing Jin · Virginia Tech5 papers (2017–2024)Lei Liu · Harbin Medical University2 papers (2017–2024)Hongzhe Ma · Harbin Medical University2 papers (2023–2024)Guoqi Li · Nanjing University of Chinese Medicine2 papers (2023–2024)Ming Hu · Harbin Medical University2 papers (2017–2018)Yangguang Su · Harbin Medical University2 papers (2024–2024)Hongbo Liu · Nanjing University of Chinese Medicine1 papers (2025–2025)Xuebin Ma · Harbin Medical University1 papers (2025–2025)Zhiju Wang · Harbin Medical University1 papers (2024–2024)D P Li · Harbin Medical University1 papers (2025–2025)Yashuang Zhao · Nantong University1 papers (2024–2024)Qingkang Meng · Harbin Medical University1 papers (2024–2024)Yangxu Lu · Harbin Medical University1 papers (2024–2024) · 1 papers (2024–2024)Lei Liu · University of Science and Technology of China1 papers (2020–2020)Xianze Zhang · Harbin Medical University1 papers (2024–2024)Meini Yu · Harbin Medical University1 papers (2024–2024)